Logo
x

Search

Subscribe Now

Specialty

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

Lonza to Divest Specialty Ingredients Business to Bain Capital and Cinven for $4.7B

  • February 10, 2021
Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M

Boston Scientific to Divest BTG's Specialty Pharma Business for ~$800M

  • December 2, 2020
Innovate Merging with RDD Pharma to Form New Gastroenterology Company Focusing on Specialty Rare and Orphan Diseases

Innovate Merging with RDD Pharma to Form New Gastroenterology Company Focusing on Specialty Rare and Orphan Diseases

  • October 8, 2019
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.